Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Strengthening of CPTx executive team with appointment of Edward Rebar, PhD, as Chief Scientific Officer. David Maier is appointed Chief Business Officer.
-
Global Settlement Network Joins Canton Network as Validator, Bringing Onchain Compliance Layer to Blockchain to Advance Institutional Adoption Global Settlement Network joins Canton as both a...
-
GAITHERSBURG, Md., April 30, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that Singapore’s Health Sciences Authority (HSA) has approved an expanded indication for...
-
Global Laparoscopy Devices Market to Register Immense Growth at a CAGR of ~9% by 2034 | DelveInsight
New York, USA, April 21, 2026 (GLOBE NEWSWIRE) -- Global Laparoscopy Devices Market to Register Immense Growth at a CAGR of ~9% by 2034 | DelveInsight The laparoscopy devices market is largely...
-
Alpha Compute Appoints Tom Richer to Advisory Board to Accelerate AI GPU Compute Infrastructure and Confidential Cloud Strategy
-
In honor of Oral, Head and Neck Cancer Awareness Month, 49 USOSM surgeon partners in 14 states will offer free oral cancer screenings this week.
-
New York, NY, April 10, 2026 (GLOBE NEWSWIRE) -- After an award-winning film festival season, including 2 Emmy Awards, 3 Webby Awards, 5 Telly Awards, and an NAACP Image Award for Outstanding Short...
-
VERO BEACH, Fla., April 01, 2026 (GLOBE NEWSWIRE) -- Bimini Capital Management, Inc. (OTCQX:BMNM) ("Bimini” or the “Company”) today announced that its wholly owned subsidiary, Bimini Advisors...
-
– Full enrollment of BLA-enabling trial complete, per prior guidance –– Topline NEXICART-2 Results Expected Q3 2026, followed by BLA submission and planned commercial launch –– Onboarded Chief Medical...
-
PAI-1 Inhibitor (MDI-2517) demonstrates good safety and tolerability profile, with Phase 2 proof-of-concept trial planned for 2026 in patients with metabolic and fibrotic diseaseCarmel Nanthakumar,...